Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 34

Results For "market"

3695 News Found

Reimagining India’s Pharmaceutical Sector: From Global Supplier to Innovation Leader
Opinion | January 07, 2026

Reimagining India’s Pharmaceutical Sector: From Global Supplier to Innovation Leader

India should explore Sustainability-Linked Incentives (SLI) targeting innovations in the 12 principles of green chemistry


Thyrocare appoints Rajdeep Panwar as Chief Commercial Officer
People | January 06, 2026

Thyrocare appoints Rajdeep Panwar as Chief Commercial Officer

Rajdeep is an accomplished business leader with a strong techno-commercial background in the healthcare and diagnostic sector


Wegovy pill marks first GLP-1 weight-loss medicine in oral form
News | January 06, 2026

Wegovy pill marks first GLP-1 weight-loss medicine in oral form

The approval introduces a needle-free alternative to injectable GLP-1 therapies


PHARMEXCIL holds high-level talks with government to boost India’s pharma exports
News | January 06, 2026

PHARMEXCIL holds high-level talks with government to boost India’s pharma exports

India’s pharmaceutical sector stands at a pivotal inflection point


Dabur sees early demand recovery, rural sales lead growth in Q3 FY26
News | January 06, 2026

Dabur sees early demand recovery, rural sales lead growth in Q3 FY26

Within India, Dabur expects its Home & Personal Care business to deliver double-digit growth,


RedHill Biopharma advances RHB-102 as once-daily oral therapy to combat GLP-1 side effects
Clinical Trials | January 06, 2026

RedHill Biopharma advances RHB-102 as once-daily oral therapy to combat GLP-1 side effects

The company is pursuing the accelerated FDA 505(b)(2) approval pathway for its once-daily oral ondansetron formulation


PathoCare Holdings valued at $1.75 billion following major third-party tender offer
News | January 06, 2026

PathoCare Holdings valued at $1.75 billion following major third-party tender offer

The company previously completed a $150 million venture investment, acquisition, and recapitalization


Valneva and Serum Institute end chikungunya vaccine partnership
News | January 06, 2026

Valneva and Serum Institute end chikungunya vaccine partnership

Valneva said regaining full rights to the vaccine will allow the company to “assume direct control over its supply chain and commercialization for endemic high-risk countries


Exports of AYUSH and herbal products touches US$ 689 million in 2024–25
News | January 05, 2026

Exports of AYUSH and herbal products touches US$ 689 million in 2024–25

India’s traditional medicine systems have also earned formal recognition in key bilateral trade agreements


Intelligent Bio Solutions taps Global MedTech giant Syrma Johari to scale production
Medical Device | January 04, 2026

Intelligent Bio Solutions taps Global MedTech giant Syrma Johari to scale production

Syrma Johari is a globally recognised medical device engineering and manufacturing organisation